PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
-15.68%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.11B
AUM Growth
+$1.11B
Cap. Flow
+$128M
Cap. Flow %
11.5%
Top 10 Hldgs %
47.87%
Holding
199
New
48
Increased
49
Reduced
18
Closed
34

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$31.1M
2
HUM icon
Humana
HUM
$20.1M
3
MDVN
MEDIVATION, INC.
MDVN
$15.6M
4
XLRN
Acceleron Pharma Inc.
XLRN
$13.9M
5
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$12.1M

Top Sells

1
DYAX
DYAX CORPORATION
DYAX
$68.4M
2
TEVA icon
Teva Pharmaceuticals
TEVA
$11.8M
3
BAX icon
Baxter International
BAX
$10.9M
4
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
$8.54M
5
NVRO
NEVRO CORP.
NVRO
$7.63M

Sector Composition

1 Healthcare 92.2%
2 Consumer Discretionary 0.11%
3 Industrials 0.05%
4 Financials 0.02%
5 Consumer Staples 0.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CTMX icon
26
CytomX Therapeutics
CTMX
$350M
$9.57M 0.84%
742,021
+99,974
+16% +$1.29M
PFNX
27
DELISTED
Pfenex Inc.
PFNX
$9.45M 0.83%
960,877
– –
CDTX icon
28
Cidara Therapeutics
CDTX
$1.61B
$9.43M 0.83%
742,858
– –
ALDR
29
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$9.18M 0.81%
+375,000
New +$9.18M
RXDX
30
DELISTED
Ignyta, Inc.
RXDX
$9.12M 0.8%
1,347,060
-465,000
-26% -$3.15M
AGTC
31
DELISTED
Applied Genetic Technologies Corporation
AGTC
$9.1M 0.8%
650,591
-210,922
-24% -$2.95M
ASRT icon
32
Assertio
ASRT
$78M
$9.06M 0.79%
650,000
+150,000
+30% +$2.09M
BAX icon
33
Baxter International
BAX
$12.1B
$9.04M 0.79%
220,000
-265,000
-55% -$10.9M
RGNX icon
34
Regenxbio
RGNX
$498M
$8.91M 0.78%
825,396
+46,183
+6% +$499K
ZYNE
35
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$8.03M 0.7%
849,350
+290,904
+52% +$2.75M
AKBA icon
36
Akebia Therapeutics
AKBA
$827M
$7.79M 0.68%
865,000
+605,000
+233% +$5.45M
VBIV
37
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$7.66M 0.67%
3,260,356
– –
EGRX
38
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$7.58M 0.67%
187,215
+54,070
+41% +$2.19M
VCEL icon
39
Vericel Corp
VCEL
$1.69B
$7.31M 0.64%
1,247,312
+941,650
+308% +$5.52M
BPMC
40
DELISTED
Blueprint Medicines
BPMC
$7.3M 0.64%
404,404
– –
EYPT icon
41
EyePoint Pharmaceuticals
EYPT
$827M
$7.14M 0.63%
2,665,000
+2,250,000
+542% +$6.03M
ACAD icon
42
Acadia Pharmaceuticals
ACAD
$4.34B
$7.14M 0.63%
255,240
+10,000
+4% +$280K
NEPT
43
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$6.75M 0.59%
6,750,444
+50,000
+0.7% +$50.4K
EVH icon
44
Evolent Health
EVH
$1.11B
$6.54M 0.57%
618,930
+471,330
+319% +$4.98M
NVO icon
45
Novo Nordisk
NVO
$252B
$6.32M 0.55%
116,660
+107,120
+1,123% +$5.81M
MRTX
46
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.84M 0.51%
+273,000
New +$5.84M
HZNP
47
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.8M 0.51%
+350,000
New +$5.8M
SIOX
48
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$5.57M 0.49%
485,000
-50,000
-9% -$574K
ANTH
49
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$5.4M 0.47%
1,492,156
+500,000
+50% +$1.81M
MYOK
50
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$5.39M 0.47%
502,894
-9
-0% -$96
1
2
3 4 5